Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

China flag China · Delayed Price · Currency is CNY
12.66
+0.01 (0.08%)
Jun 18, 2026, 3:04 PM CST
Market Cap4.80B -22.8%
Revenue (ttm)2.77B -12.6%
Net Income66.93M -55.0%
EPS0.18 -53.3%
Shares Out 379.33M
PE Ratio69.46
Forward PEn/a
Dividend0.25 (1.98%)
Ex-Dividend DateMay 15, 2026
Volume9,864,263
Open12.02
Previous Close12.65
Day's Range12.02 - 13.03
52-Week Range11.77 - 22.47
Beta0.45
AnalystsStrong Buy
Price Target38.85 (+206.87%)
Earnings DateAug 21, 2026

About SHE:300233

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China. [Read more]

Industry Chemicals
Sector Materials
Founded 2004
Employees 3,515
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300233
Full Company Profile

Financial Performance

In 2025, SHE:300233's revenue was 2.74 billion, a decrease of -18.87% compared to the previous year's 3.37 billion. Earnings were 44.19 million, a decrease of -77.55%.

Financial Statements